2023-04-19 11:30:40 ET
A Calgary-based %Biotechnology company is stealing the spotlight so far during Wednesday’s session after an announcement came out after hours Tuesday detailing the execution of a commercial agreement with Sandhill One, LLC. According to the release, upon completion of its development project with Sandhill and assuming the optimized enzyme is utilized in Sandhill's end-market manufacture, following receipt of milestone payments, it may receive a reasonably significant percent of Sandhill's end-market revenues.
Shares of %WillowBiosciences (TSX: ) (OTCQB: ) were launched at the open as traders pushed the share price up to $0.17/share (+21.43%) at the early session high. This move was a strong continuation of the success this stock has had over the last few weeks.
Willow Biosciences Inc is a Canadian biotechnology company. It has only one reportable segment engaged in developing and producing high-purity, plant-derived ingredients for consumer care, food and beverage, and pharmaceutical products. Geographically, it derives a majority of its revenue from Canada.